Navigation Links
N.C. Biotechnology Center Launches Industrial Fellowship Program
Date:7/1/2008

Companies invited to submit applications for positions

RESEARCH TRIANGLE PARK, N.C., July 1 /PRNewswire-USNewswire/ -- The North Carolina Biotechnology Center has unveiled a unique fellowship program to help postdoctoral scientists from the state's research universities transition into industry R&D careers.

The NCBC Industrial Fellowship Program will retain home-grown research talent by providing work experience in North Carolina's life-science companies. It is designed to fill a gap for scientists in need of industry experience as well as for companies in need of scientific expertise.

"We know of nowhere else in the world where there is a defined pathway for life scientists seeking to transition from academia to industry," said Rob Lindberg, Ph.D., R.A.C., director of the Biotechnology Center's Business Acceleration and Technology Out-licensing Network (BATON) program.

Many called, few chosen

North Carolina's universities conferred 280 Ph.D. degrees in the life sciences in 2006. Graduates aiming for academic research careers must then complete one or more postdoctoral fellowships to compete for junior faculty positions.

North Carolina universities presently employ roughly 3,000 postdoctoral fellows. Yet only 25 to 50 percent of them will ultimately be hired for tenure-track, academic faculty positions - rarely at the university that provided the postdoctoral training.

"Not surprisingly, many freshly minted Ph.D. scientists and postdoctoral fellows are considering futures in industry," said Lindberg.

"But unlike degree programs in fields such as engineering, law or business, graduate and post-graduate scientific training programs do not typically provide exposure to the world outside of academia as a formal component of the training."

Bottleneck on the bench

There's a bottleneck, said the Biotechnology Center's Shobha Parthasarathi, Ph.D., the technology development director and fellowship program director. As a former postdoctoral fellow at Millennium Pharmaceuticals in Massachusetts, she understands the problem first-hand.

Mid-level scientific positions typically require both postdoctoral training and commercial experience, she said, yet few companies provide transitional opportunities. Moreover, there is little consensus as to what constitutes an entry-level corporate position for a Ph.D. scientist with no industry experience. Many small- and mid-size companies can only afford to hire researchers as either technicians or as senior scientists. Ph.D. scientists coming out of academia are often dismissed as being overqualified for technical jobs but not qualified enough for senior positions.

Program details

To facilitate the connection between scientist and company, the Biotechnology Center will provide two years of salary and benefits for five NCBC Industrial Fellowship recipients per year. Eligible sponsors are North Carolina biotechnology companies that are engaged in discovery or contract research. The company must provide a senior scientist to mentor the fellow.

Fellows are Ph.D. scientists who are hired by the sponsor company as full-time employees. Additionally, NCBC fellows will have access to programs in business, intellectual property, regulatory affairs and other areas to complement their training.

Five sponsoring companies will be chosen by the Biotechnology Center for the first year of the program. The Biotechnology Center will collect scientists' applications and forward them to the chosen companies for final selection.

Call for sponsoring companies

The Biotechnology Center is currently accepting applications from sponsoring companies. Details and applications for companies and fellowship candidates are available at http://www.ncbiotech.org/fellowship.

The deadline for company applications is July 15, 2008.

The Biotechnology Center is a private, non-profit corporation supported by the N.C. General Assembly. Its mission is to provide long-term economic and societal benefits to North Carolina by supporting biotechnology research, business and education statewide.

Contact: Chris Brodie, vice president, corporate communications, chris_brodie@ncbiotech.org or Rob Lindberg, rob_lindberg@ncbiotech.org, at 919-541-9366. Visit the Biotechnology Center's Web site at http://www.ncbiotech.org.


'/>"/>
SOURCE North Carolina Biotechnology Center
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
2. New White Paper Details Strategies for Biotechnology Companies to Improve EH&S Compliance
3. Thomson Scientific to Host Pharmaceutical Vision - A Users Conference for Information, Regulatory Affairs, Competitive Intelligence and Biotechnology Professionals
4. Lixte Biotechnology Holdings, Inc. Announces the Initial Trading of Its Common Stock Under the Symbol: LIXT
5. Luminex Corporation to Present at Biotechnology Industry Organization Investor Forum
6. An Uncommon Eye: Photography Exhibit by Biotechnology Executive at BHCC Gallery
7. Onyx Pharmaceuticals to Present at Biotechnology Industry Organization Investor Forum
8. Leading Biotechnology Company Grows with StayinFront CRM
9. Kosan Biosciences to Present at the Biotechnology Industry Organization Investor Forum
10. Wyeth Pharmaceuticals Acquires Haptogen Ltd. to Boost Biotechnology Drug Discovery
11. Bionovo to Present at the Biotechnology Industry Organization (BIO) Investor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... Feb. 16, 2017 UCHealth ( Aurora, ... LungDirect for pulmonary nodule patient management. In addition to ... a spot on the lung, UCHealth looks to improve ... data entry. Stephanie Brown, RN , ... nodule patients with an Excel spreadsheet, which was extremely ...
(Date:2/16/2017)... HACKENSACK, N.J. , Feb. 16, 2017  Champions ... engaged in the development and sale of advanced technology ... of oncology drugs, today announced the addition of new ... These new models will expand Champions, product ... cancer, head and neck cancer, AML, and non-small cell ...
(Date:2/16/2017)... Feb. 16, 2017  Windtree Therapeutics, Inc. (Nasdaq: ... on developing aerosolized KL4 surfactant therapies for respiratory ... influenza study showed that aerosolized KL4 surfactant reduced ... well-established preclinical animal model. The Company believes that ... of evidence that supports the role of KL4 ...
(Date:2/16/2017)... PHOENIX and NEW YORK ... announced the near completion of their $7M Series B ... on top of the $3.5M led by Mesa Verde ... of 2016.  These resources will be directed towards further ... Test, PCDx, a comprehensive genomic profiling test and expanding ...
Breaking Biology Technology:
(Date:2/10/2017)... , Feb 10, 2017 Research ... report "Personalized Medicine - Scientific and Commercial Aspects" ... ... medicine. Diagnosis is integrated with therapy for selection of treatment ... early detection and prevention of disease in modern medicine. Biochip/microarray ...
(Date:2/8/2017)... Feb. 7, 2017  Aware, Inc. (NASDAQ: AWRE ... reported financial results for its quarter and year ended December ... of 2016 was $3.9 million compared to $6.9 million in ... quarter of 2016 was $0.6 million compared to $2.6 million ... fourth quarter of 2016 was $0.5 million, or $0.02 per ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... billion by 2021 from $8.3 billion in 2016 at ... 2016 to 2021. Report Includes - An overview ... global market trends, with data from 2015 and 2016, ... 2021. - Segmentation of the market on the basis ...
Breaking Biology News(10 mins):